Related Experiment Video
Updated: Jun 10, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Elevated Trans-mitral Pressure Gradient Predicts Surgery in Young People with Moderate-Severe Rheumatic Mitral
Jacqueline M Williamson1,2,3, Gillian A Whalley4, Ari E Horton5,6,7
1Child and Maternal Health Division, Menzies School of Health Research, Darwin, Australia. jacqui.williamson@menzies.edu.au.
Insights
In children with rheumatic heart disease and mitral regurgitation, a higher trans-mitral pressure gradient (TMPG) predicts the need for future mitral valve surgery. This finding aids in optimizing surgical timing for rheumatic heart disease patients.
Area of Science:
- Pediatric Cardiology
- Rheumatic Heart Disease Research
- Echocardiography in Valve Disease
Background:
- Rheumatic heart disease (RHD) is a significant cause of acquired heart valve disease in children, with mitral regurgitation (MR) being the most common manifestation.
- Progression of RHD often leads to left ventricular dilatation and heart failure, necessitating surgical intervention.
- The optimal timing for surgical intervention in pediatric RHD patients with MR is crucial for improving outcomes.
Purpose of the Study:
- To investigate whether an elevated trans-mitral pressure gradient (TMPG) in children with moderate to severe rheumatic MR, without significant mitral stenosis, can predict the need for future mitral valve surgery.
- To assess the predictive value of TMPG for surgical intervention in this specific pediatric population.
Main Methods:
- Retrospective review of echocardiographic studies for 116 children and young adults with moderate or severe rheumatic MR.
- Exclusion of patients with significant mitral stenosis or concurrent aortic valve disease.
- Measurement of baseline trans-mitral pressure gradient (TMPG) and tracking of subsequent mitral valve surgical interventions over up to six years.
Main Results:
- Patients with a TMPG ≥ 5 mmHg had a significantly increased risk of requiring mitral valve surgery (Hazard Ratio = 5.8).
- The proportion of patients free from surgery at one year was higher in the TMPG < 5 mmHg group (0.94) compared to the TMPG ≥ 5 mmHg group (0.62).
- Trans-mitral pressure gradient emerged as a strong, non-invasive predictor of future surgical intervention.
Conclusions:
- Trans-mitral pressure gradient is a powerful predictor of future mitral valve surgery in pediatric patients with rheumatic mitral regurgitation without significant mitral stenosis.
- This non-invasive measurement can help identify patients who may benefit from closer monitoring and optimized surgical timing.
- Utilizing TMPG can aid in proactive management strategies for children and young people affected by rheumatic heart disease.
Abstract:
Mitral regurgitation (MR) is the most common lesion in children with rheumatic heart disease (RHD). Progression of RHD results in the need for surgical intervention, the timing of which is dictated by left ventricular dilatation and the onset of heart failure symptoms. We sought to determine whether elevation in trans-mitral pressure gradient (TMPG) in those with moderate or severe rheumatic MR without significant mitral stenosis (MS) could predict the need for future surgical intervention. Echocardiographic studies were reviewed for 116 children and young people with moderate or severe rheumatic MR. Those with significant mitral stenosis or concurrent aortic valve disease were excluded. Trans-mitral pressure gradient was measured at baseline and details of mitral valve surgical intervention were retrieved from a registry database. Time to future surgery (up to six years) was compared between those with TMPG < 5 mmHg and TMPG ≥ 5 mmHg. Survival curves demonstrated an increased risk of surgery for those with TMPG ≥ 5 mmHg with Cox proportional regression analysis providing a hazard ratio of 5.8. The proportion free from mitral valve surgery at one year for the TMPG < 5 mmHg group was 0.94 (95% CI 0.86-0.97), compared to 0.62 (95% CI 0.42-0.77) in the ≥ 5 mmHg group. Trans-mitral pressure gradient is a strong predictor of future mitral valve surgery in children and young people with significant rheumatic MR without MS. This non-invasive measure could be used to signal the need for more aggressive monitoring in order to optimize the timing of intervention.
More Related Videos
04:48Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Regurgitation II: Clinical features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests